VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) on Thursday
announced that its wholly-owned subsidiary, ABcann Medicinals Inc., received
approval from Health Canada to commence cultivation in the expansion of its
Vanluven Road facility in Napanee. The expansion includes production and
product development space built to GMP standards and doubles the company’s
Ontario cultivation capacity. Cultivation in the expanded area will begin
immediately. In addition, the company has incorporated a supercritical CO2
extraction suite for production of concentrates into the facility, which is
expected to be brought on-line mid-2019. “The GMP certification of our Vanluven
expansion, expected later this year, will enable us to service the growing
international medical cannabis market. We are excited to build on our success
by introducing new high-margin, value-added products which leverage our
increased production capabilities and tap into the user insights gained from
our vast Harvest Medicine Clinic patient network,” VIVO CEO Barry Fishman
stated in the news release.
To view the full press release, visit http://ibn.fm/0kM98
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized
for trusted, high-quality products and services. It holds production and sales
licenses from Health Canada and operates world-class indoor cultivation
facilities with proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO
acquired Canna Farms, a premium cannabis company based in Hope, British
Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years
of craft cultivation experience and expertise, as well as a significant patient
base and positive cash flow. The Company is significantly expanding its
production capacity and pursuing partnership and product development
opportunities domestically, as well as in select international markets,
including Germany and Australia. VIVO also operates Harvest Medicine, a
patient-centric and highly scalable network of specialty medical cannabis
clinics as well as a free telemedicine app. VIVO has a healthy balance sheet
and is well-positioned to accelerate its growth in Canada and internationally.
For more information, visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
